These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 34700272
1. Influence of nimodipine combined with ulinastatin on neurological function and inflammatory reaction in patients with cerebral vasospasm after subarachnoid hemorrhage. Chen M, Zhang Q, Liu H, Zou W, Wei X. Clin Neurol Neurosurg; 2021 Nov; 210():106981. PubMed ID: 34700272 [Abstract] [Full Text] [Related]
2. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V. J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034 [Abstract] [Full Text] [Related]
3. Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Yin YH, Wang F, Pan YH, Wang Y, Wang Y, Luo QZ, Jiang JY. Am J Med Sci; 2009 Feb; 337(2):123-5. PubMed ID: 19214028 [Abstract] [Full Text] [Related]
4. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study. Zhang C, Zhao S, Zang Y, Zhao W, Song Q, Feng S, Hu L, Gu F. Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123 [Abstract] [Full Text] [Related]
5. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. Ott S, Jedlicka S, Wolf S, Peter M, Pudenz C, Merker P, Schürer L, Lumenta CB. Biomed Res Int; 2014 Apr; 2014():970741. PubMed ID: 24527461 [Abstract] [Full Text] [Related]
6. Evaluation function of transcranial two-dimensional and color Doppler ultrasonography (TCCS) for patients with different degrees of cerebral vasospasm before and after the nimodipine treatment. Wang JL, Li XN, Zhang YH, Li X, Yang YL. Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2757-2763. PubMed ID: 28678308 [Abstract] [Full Text] [Related]
7. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk? Adami D, Berkefeld J, Platz J, Konczalla J, Pfeilschifter W, Weidauer S, Wagner M. J Neuroradiol; 2019 Feb; 46(1):15-24. PubMed ID: 29733918 [Abstract] [Full Text] [Related]
8. Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage. Kerz T, Boor S, Ulrich A, Beyer C, Hechtner M, Mueller-Forell W. Br J Neurosurg; 2016 Oct; 30(5):549-53. PubMed ID: 27080311 [Abstract] [Full Text] [Related]
9. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage. Kerz T, Boor S, Beyer C, Welschehold S, Schuessler A, Oertel J. Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863 [Abstract] [Full Text] [Related]
11. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling. Mijailovic M, Lukic S, Laudanovic D, Folic M, Folic N, Jankovic S. Adv Clin Exp Med; 2013 Mar; 22(1):101-9. PubMed ID: 23468268 [Abstract] [Full Text] [Related]
12. Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm. Duman E, Karakoç F, Pinar HU, Dogan R, Fırat A, Yıldırım E. Interv Neuroradiol; 2017 Dec; 23(6):636-643. PubMed ID: 28956512 [Abstract] [Full Text] [Related]
13. Effects of nimodipine combined with betahistine on CRP and other inflammatory cytokines and vascular endothelial function in patients with hypertensive cerebral vasospasm. Liu X, Zhao N, Zeng K, Xiao P, Sheng P, Luo X, Wang Y. Clin Hemorheol Microcirc; 2020 Dec; 75(3):279-289. PubMed ID: 32280080 [Abstract] [Full Text] [Related]
14. [Effectiveness and safety of nimodipine in preventing cerebral vasospasm after subarachnoid hemorrhage in children]. Song Y, Qian SY, Li Y, Liu J, Li Z, Jia XL, Gao HM, Zeng JS. Zhonghua Er Ke Za Zhi; 2019 May 02; 57(5):338-343. PubMed ID: 31060125 [Abstract] [Full Text] [Related]
15. Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm. Anand S, Goel G, Gupta V. J Neurosurg Anesthesiol; 2014 Jan 02; 26(1):92-3. PubMed ID: 23774116 [No Abstract] [Full Text] [Related]
16. Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study. Dehdashti AR, Binaghi S, Uske A, Regli L. Neurol India; 2011 Jan 02; 59(6):810-6. PubMed ID: 22234190 [Abstract] [Full Text] [Related]
17. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation. Hockel K, Diedler J, Steiner J, Birkenhauer U, Ernemann U, Schuhmann MU. World Neurosurg; 2017 May 02; 101():372-378. PubMed ID: 28232152 [Abstract] [Full Text] [Related]
18. Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats. Zhao WJ, Wu C. Int J Neurosci; 2012 Oct 02; 122(10):611-7. PubMed ID: 22694164 [Abstract] [Full Text] [Related]
19. Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report. Conti A, Angileri FF, Longo M, Pitrone A, Granata F, La Rosa G. Acta Neurochir (Wien); 2008 Nov 02; 150(11):1197-202; discussion 1202. PubMed ID: 18958388 [Abstract] [Full Text] [Related]
20. Cisternal sustained release dihydropyridines for subarachnoid hemorrhage. Cook DJ, Kan S, Ai J, Kasuya H, Macdonald RL. Curr Neurovasc Res; 2012 May 02; 9(2):139-48. PubMed ID: 22475399 [Abstract] [Full Text] [Related] Page: [Next] [New Search]